The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Salmoporc lyophilisate for oral suspension for pigs

Ceva Santé AnimaleVPA10815/064/002

Main Information

Trade NameSalmoporc lyophilisate for oral suspension for pigs
Active SubstancesSalmonella typhimurium mutant, strain 421/125
Dosage FormLyophilisate for oral suspension
Licence HolderCeva Santé Animale
Licence NumberVPA10815/064/002

Group Information

ATC CodeQI09AE02 salmonella
Therapeutic ClassImmunological - Live Vaccine


License statusAuthorised
Licence Issued18/04/2019
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
VariationsNo document available

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back